Elena Prokupets, Director at C4 Therapeutics, Inc. (CCCC), sold 19,850 shares at $45.01 ($893K) on 2021-08-02, disclosed to the SEC on 2021-08-02.
Open-market sale of $893k CCCC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.00 | 11,336 | $510K | 57.1% |
| 2 | $45.01 | 4,257 | $192K | 21.4% |
| 3 | $45.01 | 4,257 | $192K | 21.4% |
| Total | $45.00 avg | 19,850 | $893K | 100% |
| Filing → |
| CCCC | SELL | 2021-09-21 | $2.1M | — | Filing → |
| CCCC | SELL | 2021-09-16 | $6.4M | — | Filing → |
| CCCC | SELL | 2021-09-14 | $527K | — | Filing → |